Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tempus AI
TEM
5
Block
XYZ
US Stock MarketDetailed Quotes
Atara Biotherapeutics (ATRA)
- 4.540
- -0.080-1.73%
Close Jan 16 16:00 ET
- 4.560
- +0.020+0.44%
Post 19:41 ET
32.73MMarket Cap1.59P/E (TTM)
5.003High4.520Low509.30KVolume4.720Open4.620Prev Close2.38MTurnover12.27%Turnover RatioLossP/E (Static)7.21MShares19.14552wk High-0.89P/B18.85MFloat Cap4.25252wk Low--Dividend TTM4.15MShs Float1638.998Historical High--Div Yield TTM10.45%Range %4.252Historical Low4.675Avg Price1Lot Size
Atara Biotherapeutics (ATRA) Cash Flow
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -145.35%-9.79M | 31.25%-7.32M | 4.98%-28.14M | 64.39%-68.72M | 51.45%-24.47M | 92.23%-3.99M | 79.84%-10.65M | 22.94%-29.61M | 28.64%-192.98M | 11.38%-50.41M |
| Net income from continuing operations | 80.36%-4.3M | 112.53%2.39M | 219.71%38.01M | 69.07%-85.4M | 79.00%-12.69M | 68.61%-21.91M | 73.21%-19.05M | 57.53%-31.75M | -20.95%-276.13M | 18.94%-60.45M |
| Depreciation and amortization | -97.07%36K | -82.26%236K | 29.04%1.8M | 4.60%5.05M | -8.71%1.1M | 1.74%1.23M | 10.74%1.33M | 14.58%1.39M | -14.58%4.83M | -3.98%1.21M |
| Other non cash items | -67.71%1.22M | -99.27%30K | 37.65%5.57M | -5.76%15.83M | -4.56%3.89M | -13.31%3.76M | -2.11%4.13M | -2.76%4.05M | 85.40%16.8M | 41.12%4.08M |
| Change In working capital | -220.04%-7.88M | -277.51%-12.77M | -599.85%-82.11M | -301.81%-30.96M | -207.89%-22.41M | 232.76%6.56M | -409.23%-3.38M | -160.01%-11.73M | 124.96%15.34M | -440.84%-7.28M |
| -Change in receivables | -275.99%-1.91M | -73.44%8.88M | -328.33%-7.39M | 433.72%32.63M | 99.57%-147K | 215.99%1.09M | 30,474.55%33.41M | -104.33%-1.73M | 115.58%6.11M | 15.08%-33.95M |
| -Change in inventory | --0 | --0 | 267.06%10.66M | 45.39%-4.43M | 94.86%-160K | 275.51%4.77M | -5.71%-2.67M | -69.90%-6.38M | -411.98%-8.12M | -96.41%-3.12M |
| -Change in payables and accrued expense | -244.42%-2.1M | 70.44%-2.94M | -38.39%-11.17M | -5.34%-13.62M | 135.31%2.95M | -80.81%1.45M | -3,454.64%-9.95M | 31.91%-8.07M | -150.59%-12.93M | -406.60%-8.36M |
| -Change in other current assets | 91.38%-321K | -14.88%1.66M | 380.78%4.54M | -191.79%-1.21M | 323.50%2.18M | -602.16%-3.73M | -30.15%1.96M | 40.95%-1.62M | -16.18%1.32M | -90.82%515K |
| -Change in other current liabilities | 48.11%-2.95M | 42.43%-5.99M | 115.11%365K | -1,579.51%-24.02M | -170.86%-5.51M | 4.87%-5.69M | -728.12%-10.41M | 50.56%-2.42M | 74.41%-1.43M | 267.33%7.77M |
| -Change in other working capital | -106.88%-596K | 8.57%-14.38M | -1,033.11%-79.11M | -166.80%-20.3M | -172.76%-21.72M | 538.96%8.67M | -3,386.47%-15.72M | 185.94%8.48M | 365.04%30.4M | -25.36%29.86M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -145.35%-9.79M | 31.25%-7.32M | 4.98%-28.14M | 64.39%-68.72M | 51.45%-24.47M | 92.23%-3.99M | 79.84%-10.65M | 22.94%-29.61M | 28.64%-192.98M | 11.38%-50.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 85.47%-2.42M | -170.46%-5.07M | 16.86%17.2M | -93.04%8.62M | -66.05%3.38M | -123.66%-16.67M | -85.46%7.2M | 345.00%14.72M | -38.97%123.87M | -80.58%9.94M |
| Net PPE purchase and sale | --44K | 1,303.45%349K | --0 | 79.47%-246K | -104.55%-90K | --0 | 94.19%-29K | 68.17%-127K | -101.32%-1.2M | -18.92%-44K |
| Net investment purchase and sale | 85.21%-2.47M | -175.00%-5.42M | 15.86%17.2M | -92.91%8.87M | -65.30%3.47M | -123.57%-16.67M | -85.54%7.23M | 364.69%14.84M | 11.28%125.06M | -80.51%9.99M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 85.47%-2.42M | -170.46%-5.07M | 16.86%17.2M | -93.04%8.62M | -66.05%3.38M | -123.66%-16.67M | -85.46%7.2M | 345.00%14.72M | -38.97%123.87M | -80.58%9.94M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -97.07%1.05M | 4,823.46%15.3M | -101.04%-250K | 2,849.35%59.28M | -121.69%-328K | 17,308.17%35.79M | -168.79%-324K | 10,172.77%24.14M | -96.21%2.01M | -95.32%1.51M |
| Net issuance payments of debt | --0 | --0 | -10.13%-250K | 5.81%-892K | -9.30%-235K | 5.29%-197K | -9.91%-233K | 27.24%-227K | -82.82%-947K | -76.23%-215K |
| Net common stock issuance | -67.84%16.34M | --0 | --0 | 2,706.69%59.95M | -113.58%-210K | --50.81M | -29,952.00%-15.03M | 3,708.44%24.37M | -90.24%2.14M | 12.44%1.55M |
| Proceeds from stock option exercised by employees | --12K | ---- | ---- | -75.22%230K | -35.36%117K | --0 | -84.87%113K | --0 | -51.69%928K | -61.41%181K |
| Net other financing activities | --0 | ---- | ---- | 93.46%-7K | --0 | --0 | 92.86%-1K | 93.55%-6K | -100.36%-107K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -97.07%1.05M | 4,823.46%15.3M | -101.04%-250K | 2,849.35%59.28M | -121.69%-328K | 17,308.17%35.79M | -168.79%-324K | 10,172.77%24.14M | -96.21%2.01M | -95.32%1.51M |
| Net cash flow | ||||||||||
| Beginning cash position | -46.27%16.9M | -60.30%13.99M | -3.12%25.18M | -72.08%25.99M | -28.24%46.6M | -31.67%31.46M | -27.93%35.23M | -72.08%25.99M | -13.39%93.09M | -2.29%64.94M |
| Current changes in cash | -173.72%-11.16M | 177.29%2.92M | -221.01%-11.19M | 98.79%-811K | 45.00%-21.42M | -19.87%15.14M | -32.71%-3.77M | 120.92%9.25M | -366.30%-67.1M | -246.27%-38.95M |
| End cash Position | -87.68%5.74M | -46.27%16.9M | -60.30%13.99M | -3.12%25.18M | -3.12%25.18M | -28.24%46.6M | -31.67%31.46M | -27.93%35.23M | -72.08%25.99M | -72.08%25.99M |
| Free cash flow | -145.35%-9.79M | 31.44%-7.32M | 5.38%-28.14M | 64.49%-68.96M | 51.32%-24.56M | 92.27%-3.99M | 79.97%-10.67M | 23.41%-29.74M | 29.28%-194.2M | 11.36%-50.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?